Nile Therapeutics completes direct public offering

Nile Therapeutics Inc. (OTCQB:NLTX), San Mateo, Calif. Business: Cardiovascular Date completed: 3/30/12 Type: Direct public offering Raised: $1.3 million Shares: 3.4 million Price: $0.40 Shares after ...